• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追求社会视角:当成本和效果涉及多个部门和决策者时的经济评估框架。

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.

机构信息

Centre for Health Economics, Alcuin a Block, University of York, York, YO10 5DD, UK.

LSE Health, London School of Economics, London, UK.

出版信息

Appl Health Econ Health Policy. 2019 Oct;17(5):577-590. doi: 10.1007/s40258-019-00481-8.

DOI:10.1007/s40258-019-00481-8
PMID:31098947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6748888/
Abstract

In most societies, resources are distributed by individuals acting in markets and by governments through some form of collective decision-making process. Economic evaluation offers a set of tools to inform collective decisions by examining the resource requirements and outcomes of alternative policies. The 'societal perspective' has been advocated, but less consideration has been given to what this should include and its practical implementation. This paper presents a framework for economic evaluation of policies with costs and outcomes falling on different sectors (e.g. health, criminal justice, education) and involving different decision makers. It extends the 'impact inventory' developed by the Second Panel on Cost-Effectiveness in Health and Medicine by considering all affected individuals and reflecting how outcomes attributed to an intervention can be compared with outcomes forgone as a result of resources not being available for other purposes. The framework sets out the series of assessments to be made, distinguishing points at which value judgements feed into the evaluation, and the implications of alternative judgements. These assessments reflect the institutional arrangements of public bodies, for example, their funding, the outcomes they consider important and their relative valuations of these outcomes. By avoiding the use of an abstract 'societal perspective', the contribution of the framework is to inform multiple decision makers with different objectives and provide practical guidance on overall societal impact.

摘要

在大多数社会中,资源的分配是由在市场中行动的个人和通过某种形式的集体决策过程的政府来进行的。经济评估通过检查替代政策的资源需求和结果,为集体决策提供了一套工具。已经提倡了“社会视角”,但对其应包括的内容及其实际实施考虑得较少。本文提出了一个框架,用于评估成本和结果落在不同部门(例如卫生、刑事司法、教育)并涉及不同决策者的政策的经济效果。它通过考虑所有受影响的个人并反映归因于干预措施的结果如何与由于资源无法用于其他目的而导致的结果相权衡,扩展了第二面板在卫生和医学中的成本效益中开发的“影响清单”。该框架列出了要进行的一系列评估,区分了价值判断纳入评估的要点,以及替代判断的影响。这些评估反映了公共机构的机构安排,例如,他们的资金、他们认为重要的结果以及他们对这些结果的相对重视。通过避免使用抽象的“社会视角”,该框架的贡献在于为具有不同目标的多个决策者提供信息,并就整体社会影响提供实用指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/29c6e32ff413/40258_2019_481_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/d6c2c5506749/40258_2019_481_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/5147862a9e57/40258_2019_481_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/f9109112630f/40258_2019_481_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/3de3be4adeea/40258_2019_481_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/dd57ec51aac1/40258_2019_481_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/c1a3e0c8188b/40258_2019_481_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/29c6e32ff413/40258_2019_481_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/d6c2c5506749/40258_2019_481_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/5147862a9e57/40258_2019_481_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/f9109112630f/40258_2019_481_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/3de3be4adeea/40258_2019_481_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/dd57ec51aac1/40258_2019_481_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/c1a3e0c8188b/40258_2019_481_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2220/6748888/29c6e32ff413/40258_2019_481_Fig7_HTML.jpg

相似文献

1
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.追求社会视角:当成本和效果涉及多个部门和决策者时的经济评估框架。
Appl Health Econ Health Policy. 2019 Oct;17(5):577-590. doi: 10.1007/s40258-019-00481-8.
2
Is the societal perspective in cost-effectiveness analysis useful for decision makers?成本效益分析中的社会视角对决策者有用吗?
Jt Comm J Qual Improv. 1999 Sep;25(9):447-54. doi: 10.1016/s1070-3241(16)30458-8.
3
Economic evaluation in cardiology.心脏病学中的经济评估。
Europace. 2011 May;13 Suppl 2:ii3-8. doi: 10.1093/europace/eur088.
4
What is the value of treating schizophrenia?治疗精神分裂症的价值是什么?
Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):963-71. doi: 10.1080/j.1440-1614.2006.01919.x.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Five pillars for societal perspective.社会视角的五个支柱
Int J Technol Assess Health Care. 2020 Apr;36(2):72-74. doi: 10.1017/S026646232000001X. Epub 2020 Jan 31.
7
A novel set of Austrian reference unit costs for comprehensive societal perspectives consistent with latest European costing methods for economic evaluations.一套新颖的奥地利参考单位成本,用于全面的社会视角,符合最新的欧洲成本效益分析方法。
Wien Klin Wochenschr. 2024 Jan;136(1-2):1-12. doi: 10.1007/s00508-022-02128-6. Epub 2022 Dec 23.
8
Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector.社会决策分析:公共部门资源决策的通用方法。
Value Health. 2024 Jul;27(7):823-829. doi: 10.1016/j.jval.2024.01.015. Epub 2024 Feb 3.
9
Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.信息价值和实施价值:应用分析框架为转移性激素难治性前列腺癌的资源分配决策提供信息。
Value Health. 2009 Mar-Apr;12(2):315-24. doi: 10.1111/j.1524-4733.2008.00431.x. Epub 2008 Jul 24.
10
Cost-effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross-sectoral analysis of an alcohol misuse intervention.公共卫生干预措施对健康和刑事司法影响的成本效益分析:一项酒精滥用干预措施的跨部门应用分析。
Health Econ. 2021 May;30(5):972-988. doi: 10.1002/hec.4229. Epub 2021 Feb 19.

引用本文的文献

1
Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention.《心血管疾病预防健康经济学宣言》要点
Pharmacoeconomics. 2025 Sep 8. doi: 10.1007/s40273-025-01537-5.
2
Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluations.权衡临床实践中基于多基因风险方法的成本与效益证据:经济评估的系统综述
Am J Hum Genet. 2025 Aug 7;112(8):1735-1753. doi: 10.1016/j.ajhg.2025.05.012. Epub 2025 Jun 12.
3
Are Economic Evaluations of Task Shifting Too Narrow in Focus? A Rapid Review.

本文引用的文献

1
Resolving the "Cost-Effective but Unaffordable" Paradox: Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts.解决“性价比高但负担不起”的悖论:估算非边际预算影响的健康机会成本。
Value Health. 2018 Mar;21(3):266-275. doi: 10.1016/j.jval.2017.10.006. Epub 2018 Jan 4.
2
Estimating a cost-effectiveness threshold for the Spanish NHS.估算西班牙国民医疗服务体系的成本效益阈值。
Health Econ. 2018 Apr;27(4):746-761. doi: 10.1002/hec.3633. Epub 2017 Dec 28.
3
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
任务转移的经济评估是否聚焦过窄?一项快速综述。
Pharmacoeconomics. 2025 May 23. doi: 10.1007/s40273-025-01507-x.
4
Cost-effectiveness of Semaglutide Compared With Other Glucose-Lowering Medications in Treating Type 2 Diabetes: A Comprehensive Systematic Review and Meta-analysis.司美格鲁肽与其他降糖药物治疗2型糖尿病的成本效益:一项全面的系统评价和荟萃分析。
Diabetes Care. 2025 Jun 1;48(6):1032-1041. doi: 10.2337/dc24-2241.
5
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation intervention.巴基斯坦糖尿病与抑郁症的模型构建:运用经济模型为干预设计提供信息及一项行为激活干预的临床试验
BMJ Open. 2025 May 19;15(5):e092158. doi: 10.1136/bmjopen-2024-092158.
6
Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts.结核病接触者中慢性病综合筛查的成本及成本效益
IJTLD Open. 2025 Mar 12;2(3):160-165. doi: 10.5588/ijtldopen.24.0625. eCollection 2025 Mar.
7
Validation of the PECUNIA reference unit costs templates in Spain: a useful tool for multi-national economic evaluations of health technologies.西班牙PECUNIA参考单位成本模板的验证:卫生技术多国经济评估的有用工具。
Cost Eff Resour Alloc. 2024 Dec 18;22(1):92. doi: 10.1186/s12962-024-00601-9.
8
The Development of a New Approach for the Harmonized Multi-Sectoral and Multi-Country Cost Valuation of Services: The PECUNIA Reference Unit Cost (RUC) Templates.一种新方法的发展,用于协调多部门和多国服务成本估值:PECUNIA 参考单位成本 (RUC) 模板。
Appl Health Econ Health Policy. 2024 Nov;22(6):783-796. doi: 10.1007/s40258-024-00905-0. Epub 2024 Aug 8.
9
Using economic analysis to inform health resource allocation: lessons from Malawi.运用经济分析为卫生资源分配提供依据:来自马拉维的经验教训。
Discov Health Syst. 2024;3(1):48. doi: 10.1007/s44250-024-00115-4. Epub 2024 Jul 15.
10
A hybrid digital parenting programme to prevent abuse of adolescents in Tanzania: statistical analysis plan for a pragmatic cluster randomised controlled trial.一种混合式数字育儿项目在坦桑尼亚预防青少年受虐:一项实用型整群随机对照试验的统计分析计划。
Trials. 2024 Jul 3;25(1):446. doi: 10.1186/s13063-024-08292-6.
估算澳大利亚卫生系统的参考增量成本-效果比。
Pharmacoeconomics. 2018 Feb;36(2):239-252. doi: 10.1007/s40273-017-0585-2.
4
CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.经济评估中社会视角的概念化:系统评价。
Int J Technol Assess Health Care. 2017 Jan;33(2):251-260. doi: 10.1017/S0266462317000526. Epub 2017 Jun 23.
5
Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.全球卫生中的成本效益阈值:采取多部门视角
Value Health. 2017 Apr;20(4):699-704. doi: 10.1016/j.jval.2016.11.009. Epub 2017 Jan 3.
6
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions.制定价值框架:反映资金决策机会成本的必要性。
Value Health. 2017 Feb;20(2):234-239. doi: 10.1016/j.jval.2016.11.021.
7
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
8
Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY.改进跨部门比较:超越与健康相关的质量调整生命年
Appl Health Econ Health Policy. 2015 Dec;13(6):557-65. doi: 10.1007/s40258-015-0194-1.
9
Distributional Cost-Effectiveness Analysis: A Tutorial.分布性成本效益分析:教程
Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23.
10
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.英国国家卫生与临床优化研究所成本效益阈值的估计方法。
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.